← Leaderboards
Jie Deng
Vanderbilt University
$2,643,979
Attributed
$3,115,092
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $706.7K · FY2015–25$1M$750K$500K$250K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,115,092 · 2
By mechanism
R01$3,115,092 · 2
Top collaborators
- Alexander Lin1 shared
- Barbara A Murphy1 shared
Most similar at Vanderbilt University
Same institution · by research overlap
- G. Roger Chalkley$9,420,741
- Beth A. Prieve$2,303,992
- David O. Francis$3,456,343
- Joey V Barnett$14,020,110
- David L Zealear$7,065,604
Others in their field
Top investigators on “Quality Of Life”
- Gary D Acton · University Of California-Davis$320,373,312
- Mitchell J Malone · Texas A&M Research Foundation$320,373,312
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$298,740,071
- Gregory H Reaman · National Childhood Cancer Foundation$264,644,476
- David R. Weir · University Of Michigan At Ann Arbor$263,050,576
- Richard K. Wilson · Washington University$198,912,538
Research focus
Quality Of LifeSwellingInvestigationParticipantSeveritiesStructureFutureHead And Neck StructureLymphatic SystemOutcome MeasureDistressDesignSiteSoft TissueCancer SurvivorFibrosisCancer TherapyHead And Neck Cancer PatientDeglutitionLate EffectsLymphedemaMeasurementAcuteAssociated Symptom
Grant awards (5)
Placebo-Controlled Phase II Randomized Clinical Trial of Photobiomodulation Therapy in Head and Neck Cancer Survivors with Chronic Lymphedema$706,669
R01 · FY2025 · CA · contact PI
Establishing Lymphedema and Fibrosis Measures in Oral Cancer Patients$482,779
R01 · FY2018 · DE · contact PI
Establishing Lymphedema and Fibrosis Measures in Oral Cancer Patients$601,225
R01 · FY2017 · DE · contact PI
Establishing Lymphedema and Fibrosis Measures in Oral Cancer Patients$644,791
R01 · FY2016 · DE · contact PI
Establishing Lymphedema and Fibrosis Measures in Oral Cancer Patients$679,628
R01 · FY2015 · DE · contact PI